Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | GNRHR | P30968 | 1/20 | 0.47 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | BRD2 | P25440 | 1/20 | 0.45 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.45 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9983147 | 0.86 | ATM (0.60) | TSHRP2RX3ATMAPOBEC3GBRD4 | |
| SCHEMBL12045850 | 0.79 | P2RX3 (0.52) | P2RX3ATMAPOBEC3GHSD17B10BRD4 | |
| SCHEMBL29989784 | 0.78 | LMNA (0.53) | P2RX3ATMAPOBEC3GBRD4BRD2 | |
| SCHEMBL15039615 | 0.76 | TSHR (0.58) | TSHRP2RX3TP53 | |
| SCHEMBL14900210 | 0.76 | BRAF (0.47) | TSHRP2RX3ATMAPOBEC3GMAPT | |
| SCHEMBL15015797 | 0.75 | TSHR (0.55) | TSHRGNRHRP2RX3ATMAPOBEC3G | |
| SCHEMBL15039711 | 0.75 | TSHR (0.57) | TSHRGNRHRP2RX3MAPTHTT | |
| SCHEMBL14725062 | 0.74 | BRAF (0.48) | P2RX3ATMAPOBEC3GMAPTHTT | |
| SCHEMBL15015852 | 0.74 | TSHR (0.56) | TSHRGNRHRP2RX3MAPTHTT | |
| SCHEMBL9983069 | 0.73 | P2RX3 (0.57) | TSHRP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630525-B2 | Triazinylmethylcycloalkylcarboxylic acid derivative, and pharmaceutical composition and use thereof | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-05-19 | — | — | US | disclosed |
| WO-2024114663-A9 | CRYSTAL FORM OF TRIAZINYL METHYL CYCLOALKYL CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | 上海海雁医药科技有限公司 | 2024-07-18 | — | — | WO | disclosed |
| WO-2024114663-A1 | CRYSTAL FORM OF TRIAZINYL METHYL CYCLOALKYL CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | 上海海雁医药科技有限公司 | 2024-06-06 | — | — | WO | disclosed |
| EP-4349816-A1 | TRIAZINYLMETHYLCYCLOALKYLCARBOXYLIC ACID DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) | 2024-04-10 | — | — | EP | disclosed |
| CN-117425643-A | Triazinylmethyl cycloalkyl carboxylic acid derivatives, pharmaceutical compositions and uses thereof | 上海海雁医药科技有限公司 | 2024-01-19 | — | — | CN | disclosed |
| WO-2022253270-A1 | TRIAZINYLMETHYLCYCLOALKYLCARBOXYLIC ACID DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 上海海雁医药科技有限公司 | 2022-12-08 | — | — | WO | disclosed |
| US-10065941-B2 | Aminotriazine derivative and pharmaceutical composition comprising the same | SHIONOGI & CO., LTD. (JP) | 2018-09-04 | — | — | US | disclosed |
| EP-3009432-B1 | AMINO-TRIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVES | SHIONOGI & CO (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20170362199-A1 | AMINOTRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2017-12-21 | — | — | US | disclosed |
| US-20170362199-A1 | AMINOTRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2017-12-21 | — | — | US | disclosed |
| US-9150546-B2 | Triazine derivative and pharmaceutical composition comprising the same | SHIONOGI & CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-9150546-B2 | Triazine derivative and pharmaceutical composition comprising the same | SHIONOGI & CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20130172317-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING AN ANALGESIC ACTIVITY COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130172317-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING AN ANALGESIC ACTIVITY COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2013-07-04 | — | — | US | disclosed |
| EP-2604595-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY | Shionogi&Co., Ltd. (JP) | 2013-06-19 | — | — | EP | disclosed |
| EP-2604595-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY | Shionogi&Co., Ltd. (JP) | 2013-06-19 | — | — | EP | disclosed |
| WO-2012020749-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY | 塩野義製薬株式会社 (JP) | 2012-02-16 | — | — | WO | disclosed |
| US-20110319414-A1 | NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110319414-A1 | NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SHIONOGI & CO., LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2399910-A1 | NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Shionogi&Co., Ltd. (JP) | 2011-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065941-B2 | Aminotriazine derivative and pharmaceutical composition comprising the same | P2RX3, P2RX2, P2RX1 | TSHR 216/4885GNRHR 1112/4885P2RX3 1/4885 |
| US-20110319414-A1 | NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | P2RX3, P2RX5, P2RX2 | TSHR 171/4885GNRHR 416/4885P2RX3 1/4885 |
| US-20130172317-A1 | TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING AN ANALGESIC ACTIVITY COMPRISING THE SAME | P2RX3, P2RX4, P2RX2 | TSHR 527/4885GNRHR 552/4885P2RX3 1/4885 |
| US-12630525-B2 | Triazinylmethylcycloalkylcarboxylic acid derivative, and pharmaceutical composition and use thereof | P2RX3, P2RX1, P2RX2 | TSHR 762/4885GNRHR 1331/4885P2RX3 1/4885 |
| US-20170362199-A1 | AMINOTRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | P2RX3, P2RX2, P2RX1 | TSHR 216/4885GNRHR 1112/4885P2RX3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.